Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

Clinical trial NCT01480479 · COMPLETED

Trial details

NCT number: NCT01480479
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Small Cell Glioblastoma Giant Cell Glioblastoma Gliosarcoma Glioblastoma With Oligodendroglial Component

Start date: 2011-11-01
Primary completion: 2016-11-01
Enrollment: 745

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.